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Abstract 
 
Previous studies have demonstrated that morphine, administered systemically or 
directly into the PAG, produces a significantly greater degree of antinociception in males 
in comparison to females.   As the midbrain periaqueductal gray (PAG) and its 
descending projections to the rostral ventromedial medulla (RVM) constitute an 
essential neural circuit for opioid-based analgesia, the present studies were conducted 
to determine if sex differences in the anatomical organization of the PAG-RVM pathway, 
and its activation during persistent inflammatory pain, could account for sex-based 
differences in opioid analgesia. In the rat, retrograde tracing was combined with Fos 
immunocytochemistry to investigate sexual dimorphism in the organization of the PAG-
RVM circuit and its activation by persistent inflammatory pain induced by intraplantar 
injection of complete Freund’s adjuvant (CFA).  The ability of morphine to suppress the 
activation of the PAG-RVM circuit was also examined.  Sexually dimorphic retrograde 
labeling was observed within the dorsomedial and lateral/ventrolateral PAG at all 
rostrocaudal levels, with females having significantly more PAG-RVM output neurons in 
comparison to males.  While no sex differences were noted in the activation of the PAG-
RVM circuit by persistent inflammatory pain, significantly more double labeled cells 
were found in males in comparison to females.  Systemic administration of morphine 
significantly suppressed CFA-induced Fos in the PAG in males only. The results of 
these studies demonstrate that both the anatomical organization, and functional 
activation, of the PAG-RVM circuit is sexually dimorphic, and may provide the 
anatomical substrate for sex-based differences in morphine analgesia.  
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Introduction 
It is becoming increasingly clear that morphine produces a differential degree of 
analgesia in males and females.  In studies using either acute (Kepler et al., 1989; Islam 
et al., 1993; Cicero et al., 1996; Cicero et al., 1997) or persistent pain models (Cook and 
Nickerson, 2005; Wang and Murphy, 2005), morphine has been shown to produce a 
significantly greater degree of analgesia in males in comparison to females.  Similar 
findings have also been reported in humans (Cepeda and Carr, 2003; Miller and Ernst, 
2004).  The midbrain periaqueductal gray (PAG), along with its descending projections 
to the rostral ventromedial medulla (RVM), is one of the primary anatomical substrates 
mediating opioid analgesia. Administration of mu opioid receptor agonists into the PAG 
produces potent analgesia that is blocked by central or systemic administration of the 
opioid antagonist naloxone (Satoh et al., 1983; Jensen and Yaksh, 1986; Bodnar et al., 
1988).  Similarly, lesions of the PAG or intra-PAG administration of mu opioid receptor 
(MOR) antagonists (Wilcox et al., 1979; Ma and Han, 1991; Zhang et al., 1998) 
attenuate the antinociceptive effects of systemic morphine.  Together, these studies 
indicate that the PAG is an essential locus for opioid-mediated analgesia.  
There are no direct projections from the PAG to the dorsal horn of the spinal 
cord.  Rather, the PAG projects heavily onto reticulospinal neurons of the RVM (Beitz, 
1982; Beitz et al., 1983; van Bockstaele et al., 1991; Cameron et al., 1995b), and this 
PAG-RVM-spinal cord circuit is essential for the analgesic actions of systemic or intra-
PAG morphine. Lesions of the RVM or dorsolateral funiculus (DLF) completely abolish 
PAG opiate-produced analgesia (Proudfit and Anderson, 1975; Basbaum et al., 1977; 
Chance et al., 1978; Mohrland and Gebhart, 1980; Proudfit, 1980; Guo and Tang, 
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1990).  In fact, lesions of the DLF attenuate all analgesic manipulations tested, including 
systemic, intraventricular and intrathecally administered morphine, indicating that the 
PAG-RVM-spinal cord pathway is the critical neural circuit for opioid-induced analgesia. 
The anatomical and physiological organization of the PAG-RVM-spinal cord 
circuit has been well characterized in a variety of species, including the rat (Basbaum 
and Fields, 1978; Behbehani and Fields, 1979; Beitz, 1982; Jones and Light, 1992; 
Williams et al., 1995), cat (Basbaum et al., 1978; Shah and Dostrovsky, 1980; Abols 
and Basbaum, 1981; Sandkuhler et al., 1987a; Sandkuhler et al., 1987b; Holstege and 
Cowie, 1989), primate (Mantyh, 1983; Gerhart et al., 1984), and rabbit (Haselton et al., 
1988).  However to date, all of these studies have been conducted exclusively in male 
animals.  Therefore, it is not known if the PAG-RVM-spinal cord circuit is organized 
anatomically in a similar manner in females.  Sex differences in the organization of this 
circuit may provide the anatomical substrate for the observed sex differences in opioid 
analgesia. 
The present studies were conducted to determine if the PAG-RVM circuit is 
organized differentially in males and females.  Additional behavioral studies were 
performed to examine the activation of this circuit by persistent inflammatory pain.  The 
results of these studies demonstrate for the first time that the PAG-RVM circuit is 
sexually dimorphic in both its anatomical organization and in its functional activation 
during persistent inflammatory pain. Collectively, these data suggest that the PAG, and 
its descending projections to the RVM, may provide the anatomical substrate for the 
observed sex differences in morphine analgesia.  Portions of this paper have been 
previously published in abstract form (Loyd and Murphy, 2004b). 
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Methods 
Subjects 
Fifteen adult intact male Sprague-Dawley rats and fifteen adult cycling female 
Sprague-Dawley rats (Zivic-Miller) were used in these experiments.  Animals were 
weight-matched (250-300g) and housed in same-sex pairs in separate rooms on a 
12:12 hour light: dark cycle (lights on at 7:00A.M.).  Access to food and water was ad 
libitum throughout the experiment except during surgery.  These studies were 
performed in strict compliance with the Institutional Animal Care and Use Committee at 
Georgia State University.  All efforts were made to minimize any possible suffering by 
the animal, and to reduce the number of animals used.   
Iontophoresis Injections 
Twelve male and twelve female rats were anesthetized with ketamine/xylazine 
(50 mg/kg / 10mg/kg; s.c.) and placed in a stereotaxic frame upon achieving a deep 
surgical plane of anesthesia.  The skull was adjusted so that bregma and lambda were 
at the same dorsoventral coordinate.  Glass micropipettes (10-20 HM) were filled with 
the retrograde tracer Fluorogold (FG; 2% soln. w/v in saline; Fluorochrome Inc.) and 
lowered into the NRM at the following coordinates (in mm): AP: -2.0 Lambda; ML: 0.0; 
DV: -8.5.  FG was iontophoresed (50/50 duty cycle, 7.5 µA current) for 20 min.  Pipettes 
remained in place for five minutes after injection to prevent backflow of tracer along the 
pipette tract and to facilitate neuronal uptake.  Special care was taken to ensure that all 
injection protocols were comparable for males and females.  Following surgery the 
animals were allowed to recover under a heat lamp in clean cages, and returned to their 
original housing facilities upon recovery from the anesthetic.   
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Inflammatory Hyperalgesia 
Ten days following surgery, persistent inflammatory pain was induced by 
injection of complete Freund’s adjuvant (CFA; Mycobacterium tuberculosis; Sigma; 200 
Hl), suspended in an oil/saline (1:1) emulsion, into the plantar surface of the right 
hindpaw. Animals were under brief Isoflo (isofluorane, USP) anesthesia during the 
plantar injections. We have previously used this procedure to induce persistent 
inflammatory pain and reported no sex differences in the degree of edema produced by 
intraplantar CFA, nor in the ensuing hyperalgesia, assayed using the paw thermal 
stimulator (Wang and Murphy, 2005).  
Morphine Analgesia 
Twenty-four hours following the induction of inflammation, all FG-injected animals 
were given a subcutaneous injection of either morphine sulfate (4.5 mg/kg, s.c.; NIDA) 
or the drug vehicle as a control. Morphine sulfate was prepared fresh in a saline vehicle 
on the day of the experiment.   
Perfusion fixation 
One hour after morphine administration, animals were given a euthanizing dose 
of Nembutal (160 mg/kg; i.p.).  Upon achieving a deep surgical plane, the animals were 
perfused transcardially (descending aorta clamped) with 100-200 ml of 0.9% sodium 
chloride containing 2% sodium nitrite as a vasodilator, followed immediately by 250 ml 
of 4% paraformaldehyde in 0.1M phosphate buffer containing 2.5% acrolein 
(Polyscience).  Following fixation, a final rinse with the sodium chloride/sodium nitrate 
solution was used to remove any residual acrolein from the animal.  Immediately 
following perfusion, the brains were removed and a mark made along the base of the 
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brain to demarcate left from right side. The tissue was stored at 40C in 30% sucrose 
solution until sectioned.  The dura and pia matter were removed and the brains were cut 
into 25µm coronal sections with a Leica 2000R freezing microtome and stored free-
floating in cryoprotectant-antifreeze solution (Watson et al., 1986) at –20oC until 
immunocytochemical processing was initiated. 
Immunocytochemistry 
A 1:6 series through the rostrocaudal axis of each brain was processed for FG 
and/or Fos immunoreactivity as previously described (Murphy and Hoffman, 2001).  
Briefly, sections were removed from the cryoprotectant-antifreeze solution, rinsed 
extensively in potassium phosphate-buffered saline, and then reacted for 20 minutes in 
1% sodium borohydride to remove excess aldehydes.  Sections were then incubated in 
primary antibody solution directed against either Fos or FG in KPBS containing 0.1% 
Triton X for 1 hour at room temperature followed by 48 hours at 4°C.  Cells containing 
Fos were identified using the polyclonal rabbit anti-Fos antibody (Oncogene, Cat. No. 
PC38; lot no. 4194) at a concentration of 1:50,000. This rabbit antiserum was prepared 
against the synthetic peptide (SGFNADYEASSSRC) corresponding to amino acids 4-17 
of human c-Fos. In western blots, this antibody recognizes the ~55 kDa c-Fos and ~62 
kDa v-Fos proteins, and does not cross-react with the ~39 kDa Jun protein 
(manufacturer’s technical information). FG containing cells were recognized using the 
polyclonal rabbit anti-Fluorogold antibody (Chemicon, Cat. No. AB153; lot no. 
25060005) at a concentration of 1:10,000. This antibody was raised against the 
chemical compound hydroxystildamidine. No cytoplasmic FG staining was present in 
animals in which the tracer failed to be ejected from the electrode. In addition, the 
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retrograde labeling pattern in the PAG noted with this antibody is identical to published 
reports using alternative retrograde tracers (Rizvi et al., 1996; Beitz et al., 1983). 
After rinsing in KPBS, the tissue was incubated for 1 hour in biotinylated goat 
anti-rabbit IgG (Jackson Immunoresearch, 1:200), rinsed in KPBS, followed by a 1 hour 
incubation in avidin-biotin peroxidase complex (1:10; ABC Elite Kit, Vector Labs).  After 
rinsing in KPBS and sodium acetate (0.175 M; pH 6.5), Fos was always visualized as a 
black reaction product using nickel sulfate intensified 3,3’-diaminobenzidine solution 
containing 0.08% hydrogen peroxide in sodium acetate buffer.  FG was always 
visualized as a brown reaction product using 3,3’-diaminobenzidine containing 0.08% 
hydrogen peroxide in Tris buffer (pH 7.2).  The reaction product was terminated after 7-
25 minutes by rinsing in sodium acetate buffer.   
For dual labeling, sections were first processed for Fos immunocytochemistry as 
described above.  Following visualization of Fos, sections were rinsed several times in 
KPBS and then incubated for 1 hour at room temperature in primary antibody directed 
against FG followed by 48 hours at 4°C. Secondary and ABC reactions are as stated 
above.  FG was visualized as a brown reaction product using 3,3’-diaminobenzidine 
containing 0.08% hydrogen peroxide in Tris buffer (pH 7.2) for a brown cytoplasmic 
reaction product.  Sections were mounted out of saline onto gelatin-subbed slides, air-
dried overnight, dehydrated in a series of graded alcohols, cleared in Histoclear, and 
cover-slipped using Histomount. 
Data Analysis and Presentation 
Previous anatomical studies have demonstrated that the PAG is not a 
homogenous structure, but rather has distinct afferents, efferents and neurochemical 
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composition that is dependent on the rostrocaudal level (van Bockstaele et al., 1991; 
Bandler and Shipley, 1994). Therefore, the number of FG+, Fos+, or Fos+FG neurons 
was determined for six rostrocaudal levels of PAG (Bregma -6.72, -7.04, -7.74, -8.00, -
8.30, -8.80). Fos counts were made ipsilateral to the CFA injected paw. In our 
preliminary studies (Loyd and Murphy, 2004), no differences were noted in the number 
of FG+ cells for the left versus right side of PAG; similarly, no laterality was observed in 
CFA induced Fos expression in the PAG. Therefore, FG, Fos and Fos+FG labeled cells 
were only counted for the side ipsilateral to the CFA injected paw. 
Results for each rostrocaudal level of the PAG are expressed as the mean +
standard error of the mean (SEM). Only animals with comparable injection sites limited 
to the RVM were used for analysis.  Neurons were counted in two PAG subdivisions: 
dorsomedial and lateral/ventrolateral; these subdivisions are clearly distinguishable 
based on the distribution of retrograde labeling from the RVM (van Bockstaele et al., 
1991; Bandler and Shipley, 1994). Sections (25 Hm thick) were immunocytochemically 
processed in a 1:6 series; therefore, each section analyzed is separated by 125 Hm. 
Cell counts were adjusted using the protocol outlined by (Guillery, 2002) taking into 
consideration that PAG somal sizes range between 11-40 Hm (Lovick and Stezhka, 
1999), with a mean somal length of 14.8 Hm (Beitz, 1985; Beitz and Shepard, 1985). 
Analysis of variance (ANOVA) was used to test for significant main effects of sex 
(male, female), PAG subdivision (dorsomedial, lateral/ventrolateral), PAG level (Bregma 
–6.72 through -8.80); treatment (morphine, saline) was included as a fourth factor where 
relevant. P<0.05 was considered significant for all analyses. To determine the PAG 
area, an image of the section was captured with a 4x objective on a Nikon Eclipse E800 
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microscope using a Sensys digital camera (Biovisions Technology, Exton, PA).  With IP 
Spectrum software (Scanalytics, Fairfax, VA), the PAG area (in mm2) was determined. 
For data presentation, a representative animal from each experimental group 
was selected and the distribution of FG and Fos within the PAG were plotted using a 
Nikon Drawing Tube attached to a Nikon Optiphot microscope. Plots were imported to 
the computer and finalized using Adobe Illustrator 10.  Photomicrographs were 
generated using a Synsys digital camera attached to a Nikon Eclipse E800 microscope.  
Images were captured with IP Spectrum software and finalized using Adobe Photoshop 
7.0.  Alterations to the images were strictly limited to enhancement of 
brightness/contrast. 
 
RESULTS  
Sexually Dimorphic Anatomical Organization of the PAG-RVM Circuit  
Figure 1 shows an example of a typical iontophoretic injection of the retrograde 
tracer Fluorogold (FG) into the RVM of a male (top; n=12) and female (bottom; n=12) 
rat.  All injections were located on the midline and dorsal to the pyramidal tract, just 
caudal to the level of the facial nucleus (Lambda –2.0).  Injections outside of the RVM 
were not included for analysis. Injection of FG into the RVM produced dense retrograde 
labeling throughout the rostral-caudal axis of the PAG in both males and females 
(Figure 2).   Within the rostral half of PAG (Bregma –6.72 - –7.64), retrogradely labeled 
cells were concentrated within the dorsomedial and lateral regions of PAG.  A few 
scattered cells were present within the ventrolateral PAG. More caudally (Bregma –8.0 - 
–8.30), retrogradely labeled cells were most prominent within the lateral and 
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ventrolateral regions of PAG.  At the caudal pole of PAG (Bregma –8.80), retrograde 
labeling was primarily localized within the dorsal half of PAG, with a few scattered cells 
present in the ventrolateral region. 
Although there were no differences in the overall distribution pattern of 
retrogradely labeled cells for males and females, sex differences in the actual number of 
FG positive cells were evident at all rostro-caudal levels of PAG.  For example, at mid-
levels of PAG (Bregma –7.64), the mean number of FG+ cells in the lateral/ventrolateral 
region was 109 + 13 for males, in comparison to 142 + 15 for females.  More caudally 
(Bregma –8.30), the mean number of retrogradely labeled cells within the 
lateral/ventrolateral PAG was 32% higher in females (175 + 19) in comparison to males 
(133 + 14). An ANOVA on the number of FG labeled cells revealed significant main 
effects for sex (F(1,248)=26.10, p<0.01), PAG subdivisions (F(1, 248)=27.40, p<0.01) 
and a significant subdivisions by rostrocaudal level interaction (F(5,248)=12.10, 
p<0.01). A significant interaction between level and subdivisions was expected based 
on previous studies demonstrating shifts in the regional distribution of PAG-RVM output 
neurons that are dependent on the rostro-caudal level of PAG (Bandler and Shipley, 
1994).  
The observed sex differences in the number of PAG-RVM output neurons was 
not due to sex differences in FG transport rates; the number of FG+ cells within layer 5 
of the motor/somatosensory cortex was comparable for males and females ((F(1,8) = 
.009, p>0.05); Figure 3).  Sex differences in retrograde labeling are not due to 
differences in the area of the PAG for males and females; no significant differences 
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were noted in the mean area (mm2) for males in comparison to females (F(1, 48)=1.70, 
p>0.05).  
Sexually Dimorphic Activation of the PAG-RVM Circuit  
The results from the above studies demonstrate that the PAG-RVM circuit is 
sexually dimorphic in its anatomical organization, with females having significantly more 
PAG-RVM output neurons than males. The next series of experiments were conducted 
to determine if the activation of the PAG-RVM circuit by persistent inflammatory pain 
was comparable for males and females.  Intraplantar injection of CFA induced extensive 
Fos expression throughout the rostral-caudal axis of PAG (Figure 4).  Fos+ cells were 
distributed throughout all regions of the PAG with no sex differences noted in the 
distribution; similarly, an ANOVA revealed no significant main effect of sex in the 
number of Fos+ cells induced by intraplantar CFA (F(1,107)=0.02, p>0.05).   
While no significant differences were noted in the overall number of Fos+ cells for 
males versus females, the number of PAG-RVM output neurons that expressed CFA-
induced Fos was significantly greater in males in comparison to females.  Figure 5 
shows the distribution of PAG cells retrogradely labeled from the RVM that co-
expressed CFA-induced Fos and an example of CFA-induced Fos and retrograde 
labeling from the RVM in the male is presented in Figure 6. At all rostrocaudal levels of 
PAG, and within all regions analyzed, dual labeled cells were more prevalent in males in 
comparison to females. An ANOVA on the number of dual labeled neurons revealed 
significant main effects for sex (F(1,108)=39.30, p<0.01), PAG subdivisions 
(F(1,108)=23.50, p<0.01) and level (F(5,108)=2.20, p<0.05).  In addition, a significant 
levels by subdivision interaction was noted (F(5,108)=6.50, p<0.01); no other 
Page 12 of 49
John Wiley & Sons
Journal of Comparative Neurology
For Peer Review
13
interactions reached significance (p>0.05).While FG/Fos+ cells were distributed within 
the dorsomedial and lateral/ventrolateral regions of PAG, sex differences in the 
activation of the PAG-RVM circuit were most evident within the lateral/ventrolateral 
PAG, where in males, approximately 50% of all PAG-RVM output neurons expressed 
Fos, in comparison to approximately 20% in females (Figure 7). An indication of the 
degree of variability in the percentile data is shown in Figure 10. 
 As females had significantly more FG+ cells in comparison to males (see Figure 
2), we also determined the percentage of CFA-induced Fos+ cells that were present in 
PAG-RVM cells.  As no differences were noted in the number or distribution of Fos in 
males versus females (see Figure 4), this would provide an indication of the percentage 
of PAG cells activated by persistent inflammatory pain that were localized in PAG-RVM 
output neurons.  As shown in Figure 8, CFA-induced Fos preferentially engaged a 
higher percentage of PAG-RVM output neurons in males in comparison to females. An 
indication of the degree of variability in the percentile data is shown in Figure 11. Similar 
to what was noted in Figure 5, this held true for all rostrocaudal levels of PAG and for 
each region examined. Together, these data indicate that while females have 
significantly more PAG-RVM output neurons, this circuit is preferentially engaged in 
males in comparison to females during persistent pain states.   
 
Morphine differentially suppresses persistent pain-induced activation of PAG-RVM  
neurons 
The above studies demonstrate that while persistent inflammatory pain activates 
a comparable number of PAG neurons in males and females, PAG-RVM output 
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neurons were activated to a greater degree in males in comparison to females. The next 
series of experiments examined the ability of morphine to suppress CFA-induced Fos in 
males versus females.  Systemic morphine administration (4.5 mg/kg, s.c.) attenuated 
CFA-induced Fos at all rostrocaudal levels of PAG in males (Figure 9); by contrast, 
comparable numbers of CFA-induced Fos+ cells were noted for saline versus morphine 
treated females.  An ANOVA revealed significant main effects of sex (F(1,225)=5.70, 
p<0.05), treatment (F(1, 225)=20.84, p<0.01), PAG subdivision (F(1, 225)=16.65, 
p<0.01, and level (F(5, 225)=5.06, p<0.01).  In addition, a significant sex by treatment 
interaction was noted (F(1, 225)=4.72, p<0.05).  Across all levels, morphine 
administration resulted in a 26%-46% reduction in Fos expression in males; by contrast 
only a 0-19% reduction in the number of Fos+ cells was noted in females.  
We next examined if morphine was preferentially acting on PAG-RVM neurons to 
suppress CFA-induced Fos.  Figure 10 shows the percentage of PAG-RVM output 
neurons that expressed CFA-induced Fos following administration of either saline or 
morphine (4.5 mg/kg, s.c.) for males and females.  An ANOVA on the number of 
FG+Fos labeled cells revealed significant main effects of sex (F(1,228)=60.57, p<0.01), 
treatment (F(1,228)=44.78, p<0.01), and PAG subdivision (F(1,228)=21.32, p<0.01), as 
well as a significant sex by treatment interaction (F(1,228)=8.15, p<0.01.  In addition, a 
significant treatment by PAG subdivision by level interaction was noted (F(5,228)=2.42, 
p<0.05), indicating that  the effect of morphine on CFA-induced Fos in PAG-RVM output 
neurons was variable and both level and region dependent.  For example, in males, 
morphine administration reduced the percentage of dual labeled cells in both the 
dorsomedial and lateral/ventrolateral PAG within the rostral pole of PAG (-6.72).  More 
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caudally, morphine administration either had no effect or actually increased the 
percentage of dual labeled cells in the dorsomedial PAG in comparison to saline treated 
animals.  Similar level and region dependent effects were noted for the 
lateral/ventrolateral PAG. In females, the percentage of PAG-RVM neurons that 
expressed CFA-induced Fos following morphine administration was comparable across 
levels. 
As morphine significantly reduced the number of CFA-induced Fos+ neurons in 
males but not females, comparing the percent change in the activation of the PAG-RVM 
circuit (%FG that contained Fos) for morphine versus saline treated males and females 
is potentially biased. Therefore, we also examined the percentage of Fos+ neurons that 
were present in PAG-RVM neurons (%Fos in FG neurons) following morphine or saline 
treatment. A decrease in the %Fos present in PAG-RVM output neurons would suggest 
that the observed morphine-induced decreases in Fos expression (see Figure 4) were 
due to an inhibitory action on PAG-RVM output neurons. By contrast, if morphine was 
primarily acting on intrinsic PAG neurons, then the percentage of Fos present in FG+ 
neurons should be comparable for morphine and saline treated animals or increased in 
morphine treated animals, presumably due to the removal of a tonic inhibitory influence. 
The results are presented in Figure 11.  Similar to what was noted in Figure 10, the 
effects of morphine on CFA-induced Fos in PAG-RVM neurons was variable across 
levels and PAG regions. For example, within the lateral/ventrolateral region of PAG of 
males, morphine increased (Bregma –8.00), decreased (Bregma –8.30) or had no effect 
(Bregma –8.80) on the percentage of Fos localized in PAG-RVM neurons. In females, 
the percentage of Fos present in PAG-RVM neurons was comparable for saline versus 
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morphine treated animals.  Together, these results suggest the influence of multiple 
mechanisms of morphine action on persistent pain induced Fos, or alternatively, natural 
variability across PAG regions and levels. 
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Discussion 
 There are now well-established sex differences in the analgesic effects of 
morphine; however, the CNS mechanisms underlying the sexually dimorphic actions of 
morphine are unknown.  As the PAG, and its descending projections to the RVM, 
constitute an essential circuit for opioid analgesia, the present studies were conducted 
to determine if the PAG-RVM pathway is sexually dimorphic in its anatomical 
organization and in its activation during persistent inflammatory pain.  The results of the 
present study demonstrate profound sex differences in both the anatomical and 
functional organization of the PAG-RVM pathway.  The action of morphine on PAG 
neurons was also found to be sexually dimorphic.  Together, these results suggest that 
the PAG-RVM pathway may provide the anatomical basis for observed sex differences 
in morphine analgesia. 
Sexually Dimorphic PAG-RVM Circuit: Functional Implications 
Retrograde tracer injection into the RVM produced dense retrograde labeling 
within the dorsomedial, lateral and ventrolateral regions of PAG; these results are 
consistent with previous anatomical studies characterizing PAG outputs to the medulla 
(van Bockstaele et al., 1991).   Interestingly, while no sex differences were noted in the 
distribution of PAG-RVM output neurons, females had significantly more retrogradely 
labeled cells in comparison to males. The most prominent sex difference in retrograde 
labeling was observed within the lateral/ventrolateral region of the PAG, where at some 
rostrocaudal levels, females had almost twice the number of retrogradely labeled 
neurons in comparison to males.  These studies are the first to demonstrate a sexually 
dimorphic organization of a primary endogenous pain pathway. 
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The lateral/ventrolateral region of PAG has been implicated in a variety of 
physiological functions, including the cardiovascular regulation (Bandler et al., 1991; 
Murphy et al., 1995), initiation of the ‘fight or flight’ response (Bandler and Carrive, 
1988; Carrive et al., 1988; Zhang et al., 1990), vocalization (Larson and Kistler, 1984; 
Larson, 1985; Zhang et al., 1994; Jurgens, 2002; Dujardin and Jurgens, 2005) and 
reproductive behavior (McCarthy et al., 1991; Ogawa et al., 1991; Ogawa et al., 1992; 
Murphy and Hoffman, 2001).  In addition, this region is a critical site for both stimulation-
produced and morphine-induced analgesia (Reynolds, 1969; Behbehani and Fields, 
1979; Fardin et al., 1984a; Fardin et al., 1984b; Morgan et al., 1991; Morgan et al., 
1992; Zhang et al., 1998). Given that morphine produces a greater degree of analgesia 
in males in comparison to females (Cicero et al., 1996; Craft et al., 1996; Bartok and 
Craft, 1997; Cicero et al., 1997; Boyer et al., 1998; Tershner et al., 2000; Barrett et al., 
2001; Cepeda and Carr, 2003; Stoffel et al., 2003; Stoffel et al., 2005; Wang and 
Murphy, 2005) and the PAG-RVM pathway is a critical circuit for opioid analgesia, we 
had initially hypothesized that if this circuit was sexually dimorphic, retrograde labeling 
from the RVM would be more prominent in males in comparison to females.  Therefore, 
subsequent experiments were conducted to examine the ‘activation’ of this circuit by a 
persistent noxious stimulus.  Intraplantar injection of the bacterium Complete Freund’s 
adjuvant is a well-established model of persistent inflammatory pain (Millan et al., 1988; 
Stein et al., 1988a).  Twenty-four hours following injection, edema and hyperalgesia are 
present in the injected paw. We have previously used this model and reported no sex 
differences in either the degree of edema produced by intraplantar CFA, or in the 
withdrawal latencies following application of a noxious thermal stimulus (Loyd et al., 
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2005; Wang and Murphy, 2005).  Hyperalgesia in animal models of inflammatory pain is 
closely linked to activation of PAG-RVM descending modulatory circuits (Morgan et al., 
1991; Williams et al., 1995) and involve both facilitation and inhibition of inflammatory 
pain (Guan et al., 2002; Miki et al., 2002; Ren and Dubner, 2002; Guan et al., 2003).  In 
the present study, persistent inflammatory pain induced extensive Fos expression 
throughout the rostrocaudal axis of the PAG, indicating comparable activation of the 
PAG in males and females.  Interestingly, while no differences were noted in either the 
number or distribution of Fos between males and females, persistent inflammatory pain 
preferentially activated the PAG-RVM circuit in males and not females. Thus, while 
females have almost twice the number of PAG-RVM output neurons in comparison to 
males, this descending modulatory circuit is not being ‘engaged’ to the same degree by 
persistent inflammatory pain in both sexes.  As activation of the PAG and its descending 
outputs to the RVM inhibits dorsal horn neuronal responses to acute noxious stimuli 
(Carstens et al., 1979; Gray and Dostrovsky, 1983; Aimone et al., 1987; Jones and 
Gebhart, 1988; Waters and Lumb, 1997; Budai and Fields, 1998), the results of the 
present study may account for reported sex differences in nociceptive thresholds 
(Berkley, 1997; Fillingim, 2000; Fillingim and Ness, 2000; Barrett et al., 2002).   
The adaptive significance of a sexually dimorphic PAG-RVM circuit is not clear.  
As mentioned above, the PAG is involved in a variety of physiological functions, and in 
females, this region is essential for the display of lordosis, the primary motor component 
of female reproductive behavior (McCarthy et al., 1991; Ogawa et al., 1991).  
Electrolytic lesions of the PAG, or direct administration of GABA antagonists, 
significantly attenuate lordosis, while stimulation of this region facilitates it (Sakuma and 
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Pfaff, 1979a; Sakuma and Pfaff, 1979b; Sakuma and Pfaff, 1980; McCarthy et al., 1991; 
Kondo et al., 1993). In addition, stimulation of the PAG has been shown to provide 
excitatory drive over RVM pre-motoneurons that innervate the axial muscles necessary 
for the display of lordosis (Cottingham et al., 1987; Cottingham et al., 1988). Together, 
this suggests that in females, PAG outputs to the RVM may be specialized for the 
modulation of somatosensory information essential for the appropriate display of 
lordosis (Rose, 1975; Robbins et al., 1990; Robbins et al., 1992), and specifically, may 
serve to increase somatosensory thresholds during reproductive behavior (Crowley et 
al., 1976; Whipple and Komisaruk, 1985; Komisaruk and Whipple, 1986).  In support, 
the PAG receives extensive projections from the lumbosacral spinal cord (Vanderhorst 
et al., 1996; Mouton et al., 2005), and spino-PAG afferents terminate preferentially in 
PAG regions containing dense retrograde labeling from the RVM (Murphy, unpublished 
observations).  Therefore, activation of the lumbosacral spinal cord by peripheral 
afferents during mounting by a male may function to activate the PAG-RVM inhibitory 
pathway, thereby increasing sensory thresholds and allowing for appropriate postural 
adjustments necessary for successful intromission by th  male.  
Sexually Dimorphic Effect of Opiates on the PAG-RVM Circuit 
Systemic morphine administration significantly attenuated CFA-induced Fos in 
males, but not females. These results are consistent with previous studies reporting 
significant sex differences in the antihyperalgesic effects of systemic morphine in 
persistent pain models (Cook and Nickerson, 2005; Wang and Murphy, 2005).  
Interestingly, while morphine clearly suppressed CFA-induced Fos in males, the effect 
of morphine on Fos expression in PAG-RVM neurons was highly variable. Indeed, 
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depending on the PAG region and rostrocaudal level, administration of morphine either 
increased, decreased, or had no effect on the percentage of PAG-RVM neurons 
expressing Fos (%FG/Fos) in comparison to saline treated animals. Similarly, analysis 
of the percentage of Fos present in FG neurons (%Fos/FG) following morphine or saline 
treatment provided no additional clear insight. Two primary mechanisms have been 
proposed to account for morphines’ action in the PAG.  First, morphine has been shown 
to hyperpolarize GABAergic interneurons that are presynaptic to PAG-RVM output 
neurons; this hyperpolarization results in the disinhibition of PAG output neurons to the 
RVM resulting in a net excitatory effect (Behbehani and Fields, 1979; Yaksh and Tyce, 
1979; Cheng et al., 1986; Moreau and Fields, 1986; Chieng and Christie, 1994; 
Commons et al., 2000; Tortorici and Morgan, 2002).  In the present study, this 
mechanism of morphine action would be reflected as a decrease in Fos expression in 
intrinsic (presumably GABAergic) neurons.  The removal of tonic GABAergic inhibition 
would result in the net activation of PAG-RVM neurons, thereby inducing Fos and 
increasing the percentage of Fos/FG neurons in morphine treated animals in 
comparison to saline.  
Morphine has also been shown to directly inhibit PAG-RVM neurons (Osborne et 
al., 1996).  Anatomical studies by Commons et al. (2002) and Wang and Wessendorf 
(Wang and Wessendorf, 2002) estimated that between 27-50% of PAG neurons 
retrogradely labeled from the RVM contain MOR; these dual labeled cells were localized 
primarily within the caudal lateral/ventrolateral PAG. In the present study, a direct 
inhibitory mechanism of morphine action would be reflected as a decrease in the 
percentage of FG+Fos labeled cells following opioid administration.    
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A precise mechanism of morphine action (presynaptic versus direct) cannot be 
discerned in the present study, and the results suggest that both mechanisms 
contributed to the suppression of persistent pain induced Fos in the PAG of males. The 
variability noted in the action of morphine on PAG-RVM neurons is not easily 
attributable to level and region-dependent differences in PAG mu opioid receptor 
expression.  Mu opioid receptors are localized throughout the rostral-caudal axis of 
PAG, with low to moderate levels of expression noted in the rostral two-thirds of PAG 
(Bregma –6.72 to –8.00) (Duncan and Murphy, 2005).  The highest level of MOR 
expression is within the caudal ventrolateral PAG (Bregma –8.30 to -8.80), and in the 
present study, the effects of morphine on Fos expression in PAG-RVM neurons were 
quite variable at this level.   
It is important to consider that while lesions of the PAG or intra-PAG naloxone 
significantly attenuate the effects of systemic morphine, they do not block it completely. 
This suggests the involvement of additional loci, including both central (Jensen and 
Yaksh, 1986; Heinricher et al., 1994) and peripheral (Stein et al., 1988b) sites of 
morphine action.  Thus, in addition to a direct action within the PAG, morphine would 
also reduce incoming noxious input to the cord at the primary afferent synapse, which 
would ultimately reduce noxious stimulus-induced Fos in PAG. 
There was no effect of morphine on CFA-induced Fos in females. These results 
concur with our recent data indicating that the ED50 for either systemic (Loyd et al., 
2005) or intra-PAG (Loyd et al., 2005) morphine is approximately two times higher in 
females in comparison to males in a model of persistent inflammatory pain.  Similar 
findings for intra-PAG morphine administration have been reported in studies utilizing 
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acute pain models (Rossi et al., 1994; Krzanowska and Bodnar, 1999; Krzanowska and 
Bodnar, 2000).   
Interestingly, recent studies report that systemic morphine simultaneously 
activates both pain inhibitory as well as pain facilitatory systems (Vanderah et al., 
2001a; Vanderah et al., 2001b).  Specifically, in rats, sub-analgesic doses of morphine 
(0.002-0.2 mg/kg) result in a hyperalgesic response, and this effect is significantly more 
pronounced in females in comparison to males (Holtman and Wala, 2005).  While the 
mechanism(s) and neural substrates underlying morphine induced hyperalgesia are 
unknown, it is interesting to speculate that in females, morphine may concurrently 
activate both pain facilitatory and inhibitory circuits within the PAG, thereby resulting in 
no change in CFA-induced Fos.  Further studies are obviously warranted.  
Unfortunately, to date, all studies examining the antinociceptive mechanisms of 
morphine action in the PAG have been conducted exclusively in males; therefore, it is 
not known whether morphine administration has the same physiological effect on PAG 
neurons in females. The PAG contains a large population of estrogen receptors (ER)
(Murphy and Hoffman, 1999; Murphy and Hoffman, 2001), and in both males and 
females, approximately 20-25% of PAG-RVM neurons contain ER (Loyd and Murphy, 
2004a). Estrogen binding to its receptor within PAG-RVM neurons may be involved in 
ligand-dependent transcriptional events, thereby influencing the expression of various 
neurotransmitters and/or membrane properties (Zakon and Dunlap, 1999). Alternatively, 
as the gene encoding Fos contains an estrogen response element (Loose-Mitchell et 
al., 1988; Wang et al., 2003), changes in cycle status may have potentially influenced 
the effect of morphine on CFA-induced Fos in females, particularly if the animals were 
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in similar stages of estrous. In the present study, the phase of the estrous cycle was not 
determined. However, if cycle status differentially affected Fos expression, then the 
degree of variability in CFA-induced Fos should be greater in females in comparison to 
males; however, this was not observed in the present study.  Alternatively, the mu 
opioid receptor is a member of the inhibitory G protein-coupled receptor superfamily, 
and in hypothalamic slices, estrogen has been shown to rapidly uncouple the mu 
receptor from G protein-gated inwardly rectifying potassium channels resulting in a 
reduced hyperpolarizati n by MOR agonists (Kelly et al., 2003; Malyala et al., 2005).  
Estrogen has also been shown to result in MOR internalization, thereby limiting the 
amount of receptor available for exogenous ligand binding (Eckersell et al., 1998). 
Lastly, we have recently reported significant sex differences in mu opioid receptor 
protein levels within the caudal lateral/ventrolateral PAG, with intact males have 11% 
higher levels of MOR protein in comparison to diestrus females (Duncan and Murphy, 
2005). Together, these studies may provide several direct mechanisms for the reduced 
potency of mu agonists noted in females.  
Summary 
 There are now well-established sex differences in the analgesic effects of 
morphine; however, the CNS mechanisms underlying the sexually dimorphic actions of 
morphine are unknown.  The PAG, and its descending projections to the RVM and 
dorsal horn of the spinal cord, constitute an essential neural circuit for opioid-based 
analgesia.  The results of the present study demonstrate for the first time that the PAG-
RVM pathway is sexually dimorphic in its anatomical organization and in its activation 
during persistent inflammatory pain.  The actions of morphine on PAG neurons were 
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also found to be sexually dimorphic.  Together, these results suggest that the PAG-
RVM pathway may provide the anatomical basis for observed sex differences in 
morphine analgesia. 
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Figure Legends 
 
Figure1. Representative examples of FG injection into the RVM of a male (top) and 
female (bottom) rat. Scale bar: 200µm. 
Figure 2. Distribution of cells retrogradely labeled from the rostral ventromedial 
medulla in males and females at six rostrocaudal levels of the periaqueductal gray.  
Each black circle represents one FG-immunoreactive cell.  Bar graphs show the mean 
number (+ S.E.M.) of FG-immunoreactive cells for the dorsomedial and 
lateral/ventrolateral regions of PAG.  
Figure 3. Photomicrographs of cortical retrograde labeling in the male (A) and female 
(B) rat (Bregma –1.0). Scale bar: 200µm. Bar graph (C) shows the mean number (+ 
S.E.M.) of retrogradely labeled cells in the cortex of males and females. Labeling was 
localized to pyramidal cells in layer 5. Dorsal counts include primarily motor cortex, 
while ventral counts are primarily somatosensory cortex.   
Figure 4. Distribution of CFA induced Fos within the periaqueductal gray of males and 
females across six rostrocaudal levels.  Each black circle represents one Fos+ cell. No 
sex differences were noted in either the distribution or number of Fos+ cells for males 
and females.  
Figure 5. Distribution of PAG-RVM output neurons that expressed CFA-induced Fos for 
males and females across six rostrocaudal levels of the PAG.  Each black circle 
represents one double-labeled (FG+Fos) cell.  Bar graphs display the mean number of 
FG/Fos cells (+ S.E.M.) for each level and region.  
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Figure 6. Color photomicrograph showing a low (A) and high (B) power example of 
single and double labeled Fos and FG labeled cells in the PAG of a male rat.  Scale bar 
= 100 Hm in panel A; scale bar = 50 Hm in panel B.  
Figure 7. Percentage of PAG-RVM neurons that were activated by persistent 
inflammatory pain (FG+Fos) in males (left) and females (right) throughout the 
rostrocaudal axis of PAG. 
Figure 8.  Percentage of Fos+ PAG neurons that were retrogradely labeled from the 
RVM (Fos+FG) in males (left) and females (right) throughout the rostrocaudal axis of 
PAG. 
Figure 9. Distribution of CFA-induced Fos (black dots) following saline (black) or 
morphine (white) administration in males (left) and females (right) along the 
rostrocaudal axis of PAG.  Each black circle represents one Fos+ cell.  Bar graphs show 
mean number of Fos+ cells (+ S.E.M.) for each treatment group broken down 
separately for the dorsomedial and lateral/ventrolateral PAG. 
Figure 10. Percentage of PAG-RVM neurons expressing CFA-induced Fos (%FG/Fos) 
following saline (black bars) or morphine (4.5 mg/kg; s.c.; white bars) in male (left) and 
female (right) rats for six rostrocaudal levels of PAG.  
Figure 11.  Percentage of CFA-induced Fos positive neurons that were retrogradely 
labeled from the RVM (%Fos/FG) following saline (black bars) or morphine (4.5 mg/kg; 
s.c.; white bars) in male (left) and female (right) rats for six rostrocaudal levels of PAG.  
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Figure1. Representative examples of FG injection into the RVM of a male (top) and female 
(bottom) rat. Scale bar: 200mm. 
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Figure 2. Distribution of cells retrogradely labeled from the rostral ventromedial medulla 
in males and females at six rostrocaudal levels of the periaqueductal gray. Each black 
circle represents one FG-immunoreactive cell. Bar graphs show the mean number (+ 
S.E.M.) of FG-immunoreactive cells for the dorsomedial and lateral/ventrolateral regions 
of PAG.  
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Figure 2. Distribution of cells retrogradely labeled from the rostral ventromedial medulla 
in males and females at six rostrocaudal levels of the periaqueductal gray. Each black 
circle represents one FG-immunoreactive cell. Bar graphs show the mean number (+ 
S.E.M.) of FG-immunoreactive cells for the dorsomedial and lateral/ventrolateral regions 
of PAG.  
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Figure 3. Photomicrographs of cortical retrograde labeling in the male (A) and female (B) 
rat (Bregma 1.0). Scale bar: 200mm. Bar graph (C) shows the mean number (+ S.E.M.) 
of retrogradely labeled cells in the cortex of males and females. Labeling was localized to 
pyramidal cells in layer 5. Dorsal counts include primarily motor cortex, while ventral 
counts are primarily somatosensory cortex.  
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Figure 4. Distribution of CFA induced Fos within the periaqueductal gray of males and 
females across six rostrocaudal levels. Each black circle represents one Fos+ cell. No sex 
differences were noted in either the distribution or number of Fos+ cells for males and 
females.  
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Figure 5. Distribution of PAG-RVM output neurons that expressed CFA-induced Fos for 
males and females across six rostrocaudal levels of the PAG. Each black circle represents 
one double-labeled (FG+Fos) cell. Bar graphs display the mean number of FG/Fos cells (+ 
S.E.M.) for each level and region.  
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Figure 5. Distribution of PAG-RVM output neurons that expressed CFA-induced Fos for 
males and females across six rostrocaudal levels of the PAG. Each black circle represents 
one double-labeled (FG+Fos) cell. Bar graphs display the mean number of FG/Fos cells (+ 
S.E.M.) for each level and region.  
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Figure 6. Color photomicrograph showing a low (A) and high (B) power example of single 
and double labeled Fos and FG labeled cells in the PAG of a male rat. Scale bar = 100 ;m
in panel A; scale bar = 50 ;m in panel B.  
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Figure 7. Percentage of PAG-RVM neurons that were activated by persistent inflammatory 
pain (FG+Fos) in males (left) and females (right) throughout the rostrocaudal axis of 
PAG. 
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Figure 8. Percentage of Fos+ PAG neurons that were retrogradely labeled from the RVM 
(Fos+FG) in males (left) and females (right) throughout the rostrocaudal axis of PAG. 
Page 45 of 49
John Wiley & Sons
Journal of Comparative Neurology
For Peer ReviewFigure 9. Distribution of CFA-induced Fos following saline (black) or morphine (white) administration in males (left) and females (right) along the rostrocaudal axis of PAG. Each black circle represents one Fos+ cell. Bar graphs show mean number of Fos+ cells 
(+ S.E.M.) for each treatment group broken down separately for the dorsomedial and 
lateral/ventrolateral PAG. 
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(+ S.E.M.) for each treatment group broken down separately for the dorsomedial and 
lateral/ventrolateral PAG. 
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Figure 10. Percentage of PAG-RVM neurons expressing CFA-induced Fos (%FG/Fos) 
following saline (black bars) or morphine (4.5 mg/kg; s.c.; white bars) in male (left) and 
female (right) rats for six rostrocaudal levels of PAG.  
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Figure 11. Percentage of CFA-induced Fos positive neurons that were retrogradely labeled 
from the RVM (%Fos/FG) following saline (black bars) or morphine (4.5 mg/kg; s.c.; 
white bars) in male (left) and female (right) rats for six rostrocaudal levels of PAG.  
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